nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Active surveillance of adverse events following childhood immunization in Singapore
|
Thoon, Koh Cheng |
|
2014 |
32 |
39 |
p. 5000-5005 6 p. |
artikel |
2 |
Anthrax vaccine adsorbed: Further evidence supporting continuing the vaccination series rather than restarting the series when doses are delayed
|
Pittman, Phillip R. |
|
2014 |
32 |
39 |
p. 5131-5139 9 p. |
artikel |
3 |
A triple gene mutant of BoHV-1 administered intranasally is significantly more efficacious than a BoHV-1 glycoprotein E-deleted virus against a virulent BoHV-1 challenge
|
Chowdhury, Shafiqul I. |
|
2014 |
32 |
39 |
p. 4909-4915 7 p. |
artikel |
4 |
Cholera toxin B subunit—Five-stranded α-helical coiled-coil fusion protein: “Five-to-five” molecular chimera displays robust physicochemical stability
|
Arakawa, Takeshi |
|
2014 |
32 |
39 |
p. 5019-5026 8 p. |
artikel |
5 |
Comparative efficacy of two next-generation Rift Valley fever vaccines
|
Kortekaas, J. |
|
2014 |
32 |
39 |
p. 4901-4908 8 p. |
artikel |
6 |
Comparison of the safety and immunogenicity of an MF59®-adjuvanted with a non-adjuvanted seasonal influenza vaccine in elderly subjects
|
Frey, Sharon E. |
|
2014 |
32 |
39 |
p. 5027-5034 8 p. |
artikel |
7 |
Contribution of TLR4 and MyD88 for adjuvant monophosphoryl lipid A (MPLA) activity in a DNA prime–protein boost HIV-1 vaccine
|
Pouliot, Kimberly |
|
2014 |
32 |
39 |
p. 5049-5056 8 p. |
artikel |
8 |
Costs of surviving meningococcal disease in Spain: Evaluation for two cases of severe meningitis and septicaemia
|
Darbà, Josep |
|
2014 |
32 |
39 |
p. 5006-5012 7 p. |
artikel |
9 |
Development of an HIV vaccine attitudes scale to predict HIV vaccine acceptability among vulnerable populations: L.A. VOICES
|
Lee, Sung-Jae |
|
2014 |
32 |
39 |
p. 5013-5018 6 p. |
artikel |
10 |
Discovery of novel cross-protective Rickettsia prowazekii T-cell antigens using a combined reverse vaccinology and in vivo screening approach
|
Caro-Gomez, Erika |
|
2014 |
32 |
39 |
p. 4968-4976 9 p. |
artikel |
11 |
Duration of post-vaccination immunity against yellow fever in adults
|
|
|
2014 |
32 |
39 |
p. 4977-4984 8 p. |
artikel |
12 |
Editorial Board/Aims and Scope
|
|
|
2014 |
32 |
39 |
p. IFC- 1 p. |
artikel |
13 |
Efficacy of the HPV-16/18 vaccine: Final according to protocol results from the blinded phase of the randomized Costa Rica HPV-16/18 vaccine trial
|
Hildesheim, Allan |
|
2014 |
32 |
39 |
p. 5087-5097 11 p. |
artikel |
14 |
Examining Ontario's universal influenza immunization program with a multi-strain dynamic model
|
Thommes, E.W. |
|
2014 |
32 |
39 |
p. 5098-5117 20 p. |
artikel |
15 |
Findings from a hepatitis B birth dose assessment in health facilities in the Philippines: Opportunities to engage the private sector
|
Patel, Minal K. |
|
2014 |
32 |
39 |
p. 5140-5144 5 p. |
artikel |
16 |
Generation of an attenuated Salmonella-delivery strains expressing adhesin and toxin antigens for progressive atrophic rhinitis, and evaluation of its immune responses in a murine model
|
Byeon, Hoyeon |
|
2014 |
32 |
39 |
p. 5057-5064 8 p. |
artikel |
17 |
Human papillomavirus (HPV) vaccination and subsequent sexual behaviour: Evidence from a large survey of Nordic women
|
Hansen, Bo T. |
|
2014 |
32 |
39 |
p. 4945-4953 9 p. |
artikel |
18 |
Immunogenicity of recombinant VP2 proteins of all nine serotypes of African horse sickness virus
|
Kanai, Yuta |
|
2014 |
32 |
39 |
p. 4932-4937 6 p. |
artikel |
19 |
Improving the Th1 cellular efficacy of the lead Yersinia pestis rF1-V subunit vaccine using SA-4-1BBL as a novel adjuvant
|
Dinc, Gunes |
|
2014 |
32 |
39 |
p. 5035-5040 6 p. |
artikel |
20 |
Induction of a robust T- and B-cell immune response in non- and low-responders to conventional vaccination against hepatitis B by using a third generation PreS/S vaccine
|
Krawczyk, Adalbert |
|
2014 |
32 |
39 |
p. 5077-5082 6 p. |
artikel |
21 |
Issues and considerations in the use of serologic biomarkers for classifying vaccination history in household surveys
|
MacNeil, Adam |
|
2014 |
32 |
39 |
p. 4893-4900 8 p. |
artikel |
22 |
Monovalent H1N1 influenza vaccine safety in pregnant women, risks for acute adverse events
|
Nordin, James D. |
|
2014 |
32 |
39 |
p. 4985-4992 8 p. |
artikel |
23 |
Optic neuritis following Varicella zoster vaccination: Report of two cases
|
Han, Sang Beom |
|
2014 |
32 |
39 |
p. 4881-4884 4 p. |
artikel |
24 |
Parents’ preferences for seasonal influenza vaccine for their children in Japan
|
Shono, Aiko |
|
2014 |
32 |
39 |
p. 5071-5076 6 p. |
artikel |
25 |
Phenotype of the anti-Rickettsia CD8+ T cell response suggests cellular correlates of protection for the assessment of novel antigens
|
Caro-Gomez, Erika |
|
2014 |
32 |
39 |
p. 4960-4967 8 p. |
artikel |
26 |
Safety and immunogenicity in man of a cell culture derived trivalent live attenuated seasonal influenza vaccine: A Phase I dose escalating study in healthy volunteers
|
Heldens, Jacco |
|
2014 |
32 |
39 |
p. 5118-5124 7 p. |
artikel |
27 |
Safety and immunogenicity of a primary series of Sabin-IPV with and without aluminum hydroxide in infants
|
Verdijk, Pauline |
|
2014 |
32 |
39 |
p. 4938-4944 7 p. |
artikel |
28 |
Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine: Results from a double-blinded, randomized Phase I clinical trial in healthy Asian volunteers
|
Low, Jenny G.H. |
|
2014 |
32 |
39 |
p. 5041-5048 8 p. |
artikel |
29 |
Safety, immunogenicity and efficacy of a recombinant tetravalent dengue vaccine: A meta-analysis of randomized trials
|
da Costa, Vivaldo G. |
|
2014 |
32 |
39 |
p. 4885-4892 8 p. |
artikel |
30 |
Safety, tolerability and immunogenicity of GS-4774, a hepatitis B virus-specific therapeutic vaccine, in healthy subjects: A randomized study
|
Gaggar, Anuj |
|
2014 |
32 |
39 |
p. 4925-4931 7 p. |
artikel |
31 |
The weight of MMRV-related febrile convulsions among other clinical factors contributing to febrile convulsions in children
|
Gavrielov-Yusim, Natalie |
|
2014 |
32 |
39 |
p. 4954-4959 6 p. |
artikel |
32 |
Transmission of foot-and-mouth disease virus from experimentally infected Indian buffalo (Bubalus bubalis) to in-contact naïve and vaccinated Indian buffalo and cattle
|
Madhanmohan, M. |
|
2014 |
32 |
39 |
p. 5125-5130 6 p. |
artikel |
33 |
Vaccination coverage and susceptibility against vaccine-preventable diseases of healthcare students in Athens, Greece
|
Karageorgou, Katerina |
|
2014 |
32 |
39 |
p. 5083-5086 4 p. |
artikel |
34 |
Vaccination status, knowledge and awareness towards hepatitis B among students of health professions in Vientiane, Lao PDR
|
Pathoumthong, Kolakoth |
|
2014 |
32 |
39 |
p. 4993-4999 7 p. |
artikel |
35 |
Vaccine focusing to cross-subtype HIV-1 gp120 variable loop epitopes
|
Cardozo, Timothy |
|
2014 |
32 |
39 |
p. 4916-4924 9 p. |
artikel |
36 |
Valuing vaccines using value of statistical life measures
|
Laxminarayan, Ramanan |
|
2014 |
32 |
39 |
p. 5065-5070 6 p. |
artikel |